QCR Holdings, Inc. QCRH
102.18 USD -1.26 (-1.22%)
At closeNov 3, 2026, 4:01 PM EST
102.18 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
101.70 Day range 103.51
74.08 52-week range 108.11
- YTD
- +22.67%
- 1 year
- +35.72%
Analyst view
Consensus: buy
Buy
Price target (mean) 112.83 +10.4% upside
Now 102.18
- Target (low)
- 107.00
- Target (mean)
- 112.83
- Target (high)
- 123.00
Ratings (0m) 6 4 buy · 2 hold · 0 sell
- Strong buy3
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.32 | 2.25 – 2.36 | 2.21 | +4.8% | 109.21M | -7.7% | 6 |
| Next quarter | 2.04 | 1.87 – 2.14 | 1.99 | +2.4% | 101.95M | +2.7% | 6 |
| Current year | 8.70 | 8.62 – 8.76 | 7.64 | +13.9% | 415.41M | +1.0% | 6 |
| Next year | 9.08 | 9.00 – 9.30 | 8.70 | +4.4% | 437.13M | +5.2% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 18, 2026 | Stephens & Co. | Initiated | — | Equal-Weight |
| Jul 27, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Jul 27, 2026 | DA Davidson | Maintained | Neutral | Neutral |
| Jul 24, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Apr 27, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Jan 30, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Jan 29, 2026 | DA Davidson | Maintained | Neutral | Neutral |
| Jan 29, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Oct 27, 2025 | Raymond James | Reiterated | Outperform | Outperform |
| Oct 27, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 9, 2025 | DA Davidson | Downgrade | Buy | Neutral |
| Jul 28, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 25, 2025 | DA Davidson | Maintained | Buy | Buy |
| Jul 25, 2025 | Keefe, Bruyette & Woods | Reiterated | Outperform | Outperform |
| Apr 24, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Apr 24, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Apr 2, 2025 | Raymond James | Maintained | Outperform | Outperform |
| Jul 29, 2024 | Keefe, Bruyette & Woods | Reiterated | Outperform | Outperform |
| Jan 29, 2024 | Raymond James | Maintained | Outperform | Outperform |
| Jan 25, 2024 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jan 25, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 31, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 31, 2023 | Raymond James | Maintained | Outperform | Outperform |
| May 1, 2023 | Keefe, Bruyette & Woods | Maintained | — | Outperform |
| Apr 6, 2023 | Raymond James | Maintained | — | Outperform |
| Jan 26, 2023 | Piper Sandler | Maintained | — | Overweight |
| Oct 31, 2022 | Raymond James | Maintained | — | Outperform |
| Sep 1, 2022 | Raymond James | Maintained | — | Outperform |
| Jul 29, 2022 | Raymond James | Maintained | — | Outperform |
| May 2, 2022 | Raymond James | Maintained | — | Outperform |
